Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Collet

Showing results (11-20 of 408) with videos related to

Pageof 41
Sort By:
JAMA Network Open|November 19, 2021
Pretreatment in the Setting of Non-ST-Elevated Acute Coronary Syndrome-When It Is Time to ChangeMichel Zeitouni, Jean-Philippe Collet
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 21, 2022
Heparin pretreatment in STEMI: is earlier always better?Jean-Philippe Collet, Michel Zeitouni
Journal of Cardiovascular Pharmacology and Therapeutics|September 2, 2009
Platelet function testing and implications for clinical practiceJean-Philippe Collet, Gilles Montalescot
JACC. Cardiovascular Interventions|December 21, 2019
The Tricuspid Valve: No Longer the Forgotten Valve!Guillaume Leurent, Jean-Philippe Collet
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 13, 2013
Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?Jean-Philippe Collet, Gilles Montalescot
European Heart Journal. Cardiovascular Pharmacotherapy|November 28, 2020
Double vs. triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: does clinical presentation matter?Andrea Rubboli, Jean-Philippe Collet
European Heart Journal|April 16, 2013
Any room left for new antiplatelet agents in acute coronary syndrome?Jean-Philippe Collet, Gilles Montalescot
JACC. Cardiovascular Interventions|August 9, 2020
Would Anyone Dare Abandon Repositioning of Self-Expanding TAVR?Olivier Barthélémy, Jean-Philippe Collet
European Heart Journal|November 13, 2020
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation - Dual versus triple antithrombotic therapyJean-Philippe Collet, Holger Thiele
Journal of Clinical Medicine|October 31, 2020
Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology GuidelinesPaul Guedeney, Jean-Philippe Collet
Pageof 41

Showing results (11-20 of 408) with videos related to

Sort By:
Pageof 41
JAMA Network Open|November 19, 2021
Pretreatment in the Setting of Non-ST-Elevated Acute Coronary Syndrome-When It Is Time to ChangeMichel Zeitouni, Jean-Philippe Collet
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 21, 2022
Heparin pretreatment in STEMI: is earlier always better?Jean-Philippe Collet, Michel Zeitouni
Journal of Cardiovascular Pharmacology and Therapeutics|September 2, 2009
Platelet function testing and implications for clinical practiceJean-Philippe Collet, Gilles Montalescot
JACC. Cardiovascular Interventions|December 21, 2019
The Tricuspid Valve: No Longer the Forgotten Valve!Guillaume Leurent, Jean-Philippe Collet
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 13, 2013
Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?Jean-Philippe Collet, Gilles Montalescot
European Heart Journal. Cardiovascular Pharmacotherapy|November 28, 2020
Double vs. triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: does clinical presentation matter?Andrea Rubboli, Jean-Philippe Collet
European Heart Journal|April 16, 2013
Any room left for new antiplatelet agents in acute coronary syndrome?Jean-Philippe Collet, Gilles Montalescot
JACC. Cardiovascular Interventions|August 9, 2020
Would Anyone Dare Abandon Repositioning of Self-Expanding TAVR?Olivier Barthélémy, Jean-Philippe Collet
European Heart Journal|November 13, 2020
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation - Dual versus triple antithrombotic therapyJean-Philippe Collet, Holger Thiele
Journal of Clinical Medicine|October 31, 2020
Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology GuidelinesPaul Guedeney, Jean-Philippe Collet
Pageof 41